Mateon announced filing of IND with FDA to evaluate antisense drug candidate OT-101 in COVID-19 patients
On Apr. 27, 2020, Mateon Therapeutics announced announced it has submitted an Investigational New Drug application to the…
On Apr. 27, 2020, Mateon Therapeutics announced announced it has submitted an Investigational New Drug application to the…
On Apr. 27, 2020, ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, entered…
On Apr. 27, 2020, Moderna announced it had submitted an Investigational New Drug application to the U.S. Food…
On Apr. 27, 2020, LabCorpᆴ announced that it will offer antibody tests for the virus that causes COVID-19….
On Apr. 27, 2020, a novel means to prevent HIV infection was developed at the University of Nebraska…
On Apr. 27, 2020, Diffusion Pharmaceuticals announced the pre-IND submission to the FDA of a planned clinical program…
On Apr. 25, 2020, the World Health Organization (WHO) there was currently ‘no evidence’ that people who have…
On Apr. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $749,999 to…
On Apr. 24, 2020, the W. M. Keck Foundation announced a $4 million gift that will help scientists…
On Apr. 24, 2020, Shelly Miller, Professor of Mechanical and Environmental Engineering, University of Colorado Boulder, reported that…
On Apr. 24, 2020, a new study led by researchers at Oxford and Guangdong Centre for Diseases Control…
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
On Apr. 23, 2020, researchers from the University of Oxford are supporting a new government study to track…
On Apr. 23, 2020, a study led by researchers at Oxford and Guangdong Centre for Diseases Control and…
On Apr. 23, 2020, the Wellcome Sanger Institute announced that two specific cell types in the nose has…
On Apr. 23, 2020, two significant international studies involving hundreds of scientists, including a human geneticist at the…
On Apr. 23, 2020, CareDx and Johns Hopkins University announced the launch of the ALARM (AlloSure Lung Allograft…
On Apr. 23, 2020, Emergent BioSolutions announced an agreement whereby Emergent will deploy its contract development and manufacturing…
On Apr. 23, 2020, Western New York healthcare and medical research leaders joined forces in an effort to…
On Apr. 22, 2020, LivaNova announced that several of its cardiopulmonary products are now permitted to be used…
On Apr. 22, 2020, LabCorp announced expanded serological testing for SARS-CoV-2, the virus that causes COVID-19, to more…
On Apr. 22, 2020, ALung Technologies announced the U.S. Food and Drug Administration (FDA) granted the Company Emergency…
On Apr. 22, 2020, UT Southwestern Medical Center scientists announced they had discovered a protein that works with…
On Apr. 22, 2020, Cocrystal Pharma announced it has expanded its previously announced license agreement with Kansas State…
On Apr. 21, 2020, Pharnext and the University Hospital Institute Mediterranee Infection in France, announced a new joint…
On Apr. 21, 2020, a panel of U.S. physicians, statisticians, and other experts developed treatment guidelines for coronavirus…
On Apr. 21, 2020, the National Science Foundation (NSF) issued a letter to researchers inviting proposals for rapid…
On Apr. 21, 2020, researchers at the U.S. Department of Veterans Affairs’ (VA) Providence VA Medical Center began…
On Apr. 21, 2020, BioSig Technologies announced that subsidiary ViralClear Pharmaceuticals, had submitted an application for Vicromax(tm) (merimepodib,…
On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…